Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03139448 · ClinicalTrials.gov registry record · NA

Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy

A NA study of Colonoscopy and Ventilation, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
174
Enrollment target
1
Study location

NCT03139448 is a NA study of Colonoscopy and Ventilation that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 174 participants, below the 493-participant average among 20 other Colonoscopy trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03139448, a NA study of Colonoscopy and Ventilation, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
174 participants
Enrollment target
1
Study location

Study Summary

Nasal continuous positive airway pressure (nCPAP) has been shown to effectively relieve upper airway obstruction in patients with OSA as it creates a pneumatic stent in the hypopharynx that reduces obstruction and allows for continuous oxygenation. Nasal ventilation was also proven to be more effective than combined oral-nasal ventilation during induction of general anesthesia in adult subjects. However, it is not clear if nasal mask can be used safely for oxygenation and ventilation in patients undergoing colonoscopy. The SuperNO2VA™ device is a new commercially available nasal mask that provides both nasal CPAP and nasal mask ventilation. The objective of this study is to compare the efficacy of oxygenation and ventilation during colonoscopy using the novel nasal mask, SuperNO2VA™, and standard care with nasal cannula.

Interventions

  • DEVICE Oxygen via nasal cannula
  • DEVICE Oxygen via SuperNO2VA nasal mask

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2017-05-17
Est. Completion 2017-10-06
Phase NA

What the Registry Record Tells You About NCT03139448

The ClinicalTrials.gov registry entry for NCT03139448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 493-participant average among 20 other Colonoscopy trials with a reported enrollment target (65% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Colonoscopy appearing as the primary indexed condition, and to 2 interventions - of which Oxygen via nasal cannula is the first listed.

NCT03139448 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03139448 about?

NCT03139448 is a clinical study titled "Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy". Nasal continuous positive airway pressure (nCPAP) has been shown to effectively relieve upper airway obstruction in patients with OSA as it creates a pneumatic stent in the hypopharynx that reduces obstruction and allows for continuous oxygenation. Nasal ventilation was also proven to be more effect...

What is the current status of trial NCT03139448?

This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2017-05-17. Estimated completion is 2017-10-06.

What conditions does trial NCT03139448 study?

This clinical trial studies the following conditions: Colonoscopy, Ventilation, Oxygenation.

What interventions are being tested in trial NCT03139448?

The interventions under investigation include: Oxygen via nasal cannula (DEVICE), Oxygen via SuperNO2VA nasal mask (DEVICE).

Who is sponsoring clinical trial NCT03139448?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03139448 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonoscopy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.